SCHEMBL30939791

SCHEMBL30939791

CCCCCCCCCCCCCCCCOCCCOP(=O)(OCOC(=O)OC(C)C)OC[C@@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@H](CCC(=O)O)[C@H]1CCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30939818 0.92 TMPRSS2 (0.30) —
SCHEMBL31684092 0.89 TMPRSS2 (0.38) —
SCHEMBL31684098 0.89 TMPRSS2 (0.38) —
SCHEMBL31684218 0.89 TMPRSS2 (0.38) —
SCHEMBL31684130 0.85 TMPRSS2 (0.30) —
SCHEMBL31684099 0.85 TMPRSS2 (0.30) —
SCHEMBL31684117 0.85 TMPRSS2 (0.30) —
SCHEMBL30939836 0.85 TMPRSS2 (0.30) —
SCHEMBL31684100 0.85 TMPRSS2 (0.30) —
SCHEMBL31684150 0.85 TMPRSS2 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024120464-A1 NUCLEOTIDE ANALOG, AND COMPOSITION AND USE THEREOF 深圳市塔吉瑞生物医药有限公司 2024-06-13 — — WO disclosed
Send feedback